As Use of Foreign Drug Trials Grows, FDA Oversight May Not Be Keeping Up

The increasing reliance on foreign clinical trials for testing new drugs has led to concerns about the ability of the US Food and Drug Administration (FDA) to monitor such research, according to a US government report.